BR9500365A - Composto composição farmacêutica e processo para a preparação de um composto - Google Patents

Composto composição farmacêutica e processo para a preparação de um composto

Info

Publication number
BR9500365A
BR9500365A BR9500365A BR9500365A BR9500365A BR 9500365 A BR9500365 A BR 9500365A BR 9500365 A BR9500365 A BR 9500365A BR 9500365 A BR9500365 A BR 9500365A BR 9500365 A BR9500365 A BR 9500365A
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical composition
mixed
components
Prior art date
Application number
BR9500365A
Other languages
English (en)
Inventor
Robin David Grey Cooper
Thalia Ioanna Nicas
Michael John Rodriguez
Nancy June Snyder
Richard Craig Thompson
Mark James Zweifel
Bret Eugene Huff
John Thomas Quatroche
Michael Aelxander Staszak
Stephen Charles Wilkie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9500365A publication Critical patent/BR9500365A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9500365A 1994-01-28 1995-01-27 Composto composição farmacêutica e processo para a preparação de um composto BR9500365A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18939394A 1994-01-28 1994-01-28
US35641394A 1994-12-15 1994-12-15

Publications (1)

Publication Number Publication Date
BR9500365A true BR9500365A (pt) 1995-10-17

Family

ID=26885101

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9500365A BR9500365A (pt) 1994-01-28 1995-01-27 Composto composição farmacêutica e processo para a preparação de um composto

Country Status (30)

Country Link
US (1) US5843889A (pt)
EP (3) EP1016670B1 (pt)
JP (1) JP3756539B2 (pt)
KR (1) KR100388867B1 (pt)
CN (1) CN1071334C (pt)
AT (3) ATE253077T1 (pt)
AU (1) AU703106B2 (pt)
BR (1) BR9500365A (pt)
CA (3) CA2546625C (pt)
CO (1) CO4600679A1 (pt)
CZ (2) CZ292895B6 (pt)
DE (3) DE69532013T2 (pt)
DK (3) DK0667353T3 (pt)
EG (1) EG25884A (pt)
ES (3) ES2204444T3 (pt)
FI (3) FI117095B (pt)
HU (1) HU225164B1 (pt)
IL (1) IL112457A (pt)
MY (1) MY128335A (pt)
NO (1) NO323103B1 (pt)
NZ (1) NZ270387A (pt)
PE (1) PE40996A1 (pt)
PL (1) PL180961B1 (pt)
PT (3) PT1031576E (pt)
RU (1) RU2145609C1 (pt)
SG (1) SG52719A1 (pt)
SI (2) SI0667353T1 (pt)
TW (1) TW457248B (pt)
UA (1) UA43323C2 (pt)
YU (1) YU4995A (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
ID18900A (id) * 1996-11-21 1998-05-20 Lilly Co Eli Alkilasi menurun dari gliko peptida anti biotik
US5939382A (en) * 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5977063A (en) * 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5919771A (en) * 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
DE69936052T2 (de) 1998-05-01 2008-01-17 Eli Lilly And Co., Indianapolis N1 modifizierte glycopeptide
US6710168B1 (en) * 1999-05-19 2004-03-23 The Trustees Of The University Of Princeton Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
NZ509165A (en) * 1998-07-14 2003-08-29 Univ Princeton Glycopeptide antobiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
CA2336445C (en) 1998-12-23 2011-07-19 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AU2001257163A1 (en) * 2000-04-25 2001-11-07 Merck And Co., Inc. Glycopeptide antibacterial compounds and methods of using same
CN1223378C (zh) 2000-05-02 2005-10-19 施万制药 含有糖肽抗生素和环糊精的药物组合物
CN100532392C (zh) * 2000-05-02 2009-08-26 施万制药 还原性烷基化方法
US6770621B2 (en) 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
WO2001098329A1 (en) 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
ES2302733T3 (es) 2000-06-22 2008-08-01 Theravance, Inc. Derivados carboxi-sacaridos de glucopeptido.
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
KR20060091049A (ko) * 2002-08-30 2006-08-17 케이.유.루벤 리서치 앤드 디벨럽먼트 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용
US20050013854A1 (en) 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
US7521418B2 (en) 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
ES2298821T3 (es) * 2003-07-22 2008-05-16 Theravance, Inc. Utilizacion de un agente antifungico de equinocandina en combinacion con un agente antibacteriano glicopeptidico.
EP1818340A4 (en) * 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp MONOMERIC ANTIBIOTIC DERIVATIVES OF GLYCOPEPTIDES
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7918313B2 (en) 2005-04-01 2011-04-05 Buckeye Technologies Inc. Nonwoven material for acoustic insulation, and process for manufacture
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
WO2009081958A1 (ja) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. グリコペプチド抗生物質配糖化誘導体
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
CN101343313B (zh) * 2008-09-03 2011-11-16 南京农业大学 一种葡萄糖二肽类化合物及其制备方法和用途
ES2741282T3 (es) 2011-05-05 2020-02-10 Matinas Biopharma Nanotechnologies Inc Composiciones de cocleato y métodos de elaboración y uso de las mismas
CN107759672A (zh) * 2013-08-19 2018-03-06 南京爱斯药业有限公司 万古霉素衍生物、制备方法及其应用
EP3049115A1 (en) 2013-09-23 2016-08-03 Jawaharlal Nehru Centre For Advanced Scientific Research Vancomycin-sugar conjugates and uses thereof
CA2955256C (en) 2014-07-17 2023-02-14 The Medicines Company High purity oritavancin and method of producing same
KR102603756B1 (ko) 2014-11-06 2023-11-16 셀리아 파마슈티칼즈 에이피에스 글리코펩티드 조성물
US20170342110A1 (en) * 2014-12-25 2017-11-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药（苏州）股份有限公司 一种奥利万星的制备方法
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN107434823B (zh) * 2016-05-26 2021-11-16 江苏恒瑞医药股份有限公司 一种奥利万星中间体a82846b的纯化方法
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
CN109053864B (zh) * 2018-07-10 2021-08-24 丽珠集团新北江制药股份有限公司 一种制备奥利万星的方法
CN109053865B (zh) * 2018-07-20 2021-04-13 丽珠集团新北江制药股份有限公司 一种羧基保护制备奥利万星的方法
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US3338786A (en) * 1966-07-29 1967-08-29 American Cyanamid Co Antibiotic av290 and production thereof
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
IT1173329B (it) * 1984-02-21 1987-06-24 Lepetit Spa Procedimento per la trasformazione quantitativa di teicoplanina a2 fattore 1 in teicoplanina a2 fattore 3
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
GB8701872D0 (en) * 1987-01-28 1987-03-04 Lepetit Spa N15-alkyl & n15,n15-dialkyl derivatives
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
PT90366A (pt) * 1988-04-28 1989-11-10 Beecham Group Plc Processo para a producao de compostos glicopeptidicos
CA1339808C (en) * 1988-10-19 1998-04-07 Manuel Debono Glycopeptide antibiotics
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
US5185320A (en) * 1989-04-03 1993-02-09 Gruppo Lepetit S.P.A. O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin
ATE87502T1 (de) * 1989-12-11 1993-04-15 De Beers Ind Diamond Schleifprodukte.
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
RU2125058C1 (ru) * 1991-07-29 1999-01-20 Группо Лепетит С.П.А. Производное антибиотика а 40926, способы его получения, фармацевтическая композиция

Also Published As

Publication number Publication date
JP3756539B2 (ja) 2006-03-15
IL112457A0 (en) 1995-03-30
PT1016670E (pt) 2003-12-31
SG52719A1 (en) 1998-09-28
PT667353E (pt) 2004-03-31
ES2210274T3 (es) 2004-07-01
ATE248856T1 (de) 2003-09-15
EP0667353B1 (en) 2003-10-29
EP1016670A1 (en) 2000-07-05
ES2220335T3 (es) 2004-12-16
CZ18495A3 (en) 1995-08-16
EP0667353A1 (en) 1995-08-16
PL306976A1 (en) 1995-08-07
KR100388867B1 (ko) 2003-10-08
MY128335A (en) 2007-01-31
UA43323C2 (uk) 2001-12-17
YU4995A (sh) 1998-07-10
CA2141106A1 (en) 1995-07-29
DE69531709T2 (de) 2004-07-15
JPH07258289A (ja) 1995-10-09
RU2145609C1 (ru) 2000-02-20
ATE266042T1 (de) 2004-05-15
HUT68715A (en) 1995-07-28
DE69532013T2 (de) 2004-07-08
DK1031576T3 (da) 2004-08-16
FI950374A0 (fi) 1995-01-27
FI20050513A (fi) 2005-05-13
NO950298D0 (no) 1995-01-26
FI950374A (fi) 1995-07-29
CZ292895B6 (cs) 2003-12-17
SI0667353T1 (en) 2004-04-30
AU1138995A (en) 1995-08-10
EP1031576A3 (en) 2000-12-27
NO323103B1 (no) 2007-01-02
PE40996A1 (es) 1996-10-14
CA2546910A1 (en) 1995-07-29
RU95101039A (ru) 1996-10-27
PT1031576E (pt) 2004-08-31
HU225164B1 (en) 2006-07-28
EG25884A (en) 2012-09-24
FI117096B (fi) 2006-06-15
SI1016670T1 (en) 2004-02-29
KR950032274A (ko) 1995-12-20
CA2141106C (en) 2007-01-23
CA2546625A1 (en) 1995-07-29
HU9500230D0 (en) 1995-03-28
EP1031576B1 (en) 2004-05-06
DE69532013D1 (de) 2003-12-04
ATE253077T1 (de) 2003-11-15
NO950298L (no) 1995-07-31
AU703106B2 (en) 1999-03-18
DE69531709D1 (de) 2003-10-09
CN1119649A (zh) 1996-04-03
NZ270387A (en) 1996-11-26
ES2204444T3 (es) 2004-05-01
CN1071334C (zh) 2001-09-19
DK0667353T3 (da) 2004-03-22
US5843889A (en) 1998-12-01
TW457248B (en) 2001-10-01
FI117095B (fi) 2006-06-15
EP1031576A2 (en) 2000-08-30
EP1016670B1 (en) 2003-09-03
DK1016670T3 (da) 2004-01-05
CA2546910C (en) 2010-09-14
DE69533004D1 (de) 2004-06-09
FI117097B (fi) 2006-06-15
CZ292921B6 (cs) 2004-01-14
DE69533004T2 (de) 2005-04-07
IL112457A (en) 2004-06-20
CO4600679A1 (es) 1998-05-08
CA2546625C (en) 2008-09-09
FI20050512A (fi) 2005-05-13
PL180961B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
BR9500365A (pt) Composto composição farmacêutica e processo para a preparação de um composto
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
BR9609780A (pt) Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9505107A (pt) Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
BR9508320A (pt) Processo para a preparação de um composto e cultura biologicamente
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
BR9103479A (pt) Composto,estereoisomero,composicao farmaceutica e processo para a preparacao de um composto
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR9703403B1 (pt) compostos, processo para preparação de compostos, utilização de composto e processo para preparação de composição farmacêutica.
BR9606527A (pt) Epímeros processo para a preparação de um epimero composição farmacêutica que compreende um epímero e composto
BR9501945A (pt) Composto processo composições farmacêuticas uso e processo para tratamento de mamíferos

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 27/01/2015